EEG microstate analysis distinguishes Alzheimer’s disease and frontotemporal dementia from healthy controls, suggesting its diagnostic potential.
Background and Objectives: Alzheimer’s disease (AD) and frontotemporal dementia (FTD) present overlapping clinical and neuroanatomical features, complicating early diagnosis. This study evaluated whether EEG microstate analysis can provide reliable markers to distinguish dementia patients from healthy controls. Materials and Methods: Resting-state EEG was recorded from 36 AD patients, 23 FTD patients, and 29 healthy controls. Preprocessing and microstate analysis were conducted using the MICROSTATELAB pipeline in EEGLAB. Clustering solutions ranging from four to seven classes were tested, with grand mean fitting and variance thresholds. Temporal parameters (duration, occurrence, coverage) and their ratio-normalized forms were compared across groups using ANCOVA and nonparametric tests. Associations with Mini-Mental State Examination (MMSE) scores were assessed by regression analyses. Results: Four- and seven-class clustering solutions achieved high variance overlap with published microstate templates. In the four-class solution, temporal parameters of microstates B and D significantly differentiated controls from dementia groups, while in the seven-class solution, microstates C and G were most informative. Ratio-normalized parameters improved group discrimination and were associated with MMSE scores. Conclusions: EEG microstates capture disease-related alterations in large-scale brain dynamics that differentiate dementia patients from healthy individuals.
No takes yet. Share an insight, caveat, or question.
Jinwon Chang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: